Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3480 of 6351
-
Gene hunt in peru: could ancestry hold key to autoimmune diseases?
Knowledge-focused Recruiting nowBackground: Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause these diseases have been well studied in people with European and Asian ancestors. But some diseases behave differently in people who are native to North and Sou…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 10:00 UTC
-
Supplement urolithin a tested for blood sugar boost in older adults
Symptom relief Recruiting nowBackground: As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and levels of blood glucose (sugar) rise. This can lead to illnesses such as diabetes. Urolithin A (UA) is a natural nutritional supplement that may improve how the b…
Sponsor: National Institute on Aging (NIA) • Aim: Symptom relief
Last updated Sep 10, 2026 10:00 UTC
-
Can eye movements reveal the Brain's visual priorities?
Knowledge-focused Not yet recruitingBackground: Vision is vital for many of our daily activities. Researchers want to learn more about how we aim our eyes (that is, what images, such as faces, immediately attract our attention) and how we direct our attention (that is, what we see and what we ignore). Objective: …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 10:00 UTC
-
Could your morning cereal boost brainpower?
Knowledge-focused Recruiting nowThe purpose of this study is to examine appetite and cognition responses following consumption of a ready-to-eat breakfast cereal.
Sponsor: General Mills • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Can a new tampon match the safety of marketed ones?
Disease control Recruiting nowA Randomized, Open-Label, Evaluator-Blinded, Cross-Over Clinical Study to Confirm the Safety and Tolerability of an Ultra Absorbency Menstrual Tampon Compared to a Commercially Marketed Tampon
Sponsor: Lyv Life Inc. (dba: Cora) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Zoom workouts may keep seniors steady on their feet
Symptom relief Not yet recruitingDual-task training combines movement with cognitive tasks to improve gait, balance, and thinking. This study will compare tele-supervised versus onsite dual-task balance training in older adults at risk of falls. Sixty participants aged 65+ will be randomly assigned to either r…
Sponsor: Prince Sattam Bin Abdulaziz University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Five cosmetic formulas put to the test for fading UV tans
Symptom relief Not yet recruitingThis is a double-blind randomized, complete block design study on Chinese population, expecting approximately 18 participants recruited and at least 10 participants to complete the whole 9-week study. The study test sites will receive a single 2MED UV radiation .
Sponsor: Unilever R&D • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Can a new italian questionnaire unlock the fear behind jaw pain?
Knowledge-focused Not yet recruitingThis observational, cross-sectional study aims to translate, culturally adapt, and psychometrically validate the Italian version of the Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD-ITA). Patients referred to the TMD outpatient clinic of the Department of…
Sponsor: Alessandro Aquino • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Will a common seizure drug alter the fate of an experimental medicine?
Knowledge-focused Not yet recruitingThe main objective of this trial is to investigate the effect of carbamazepine, a strong CYP3A4 inducer on the pharmacokinetics of verducatib at steady state.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
New brain test aims to unravel language confusion in dementia
Diagnosis Not yet recruitingThis protocol describes a study aimed at evaluating the psychometric properties of the ExéSem battery, developed to differentiate semantic deficits from executive semantic impairments in patients with post-lesional or neurodegenerative anomia. Currently available tools do not all…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Can two different factories make the same cancer drug work the same?
Knowledge-focused Not yet recruitingThe main objective of this trial is to establish the bioequivalence of Zongertinib tablets from two different manufacturers following oral administration.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
New injectable filler aims to restore lost cheek volume
Symptom relief Recruiting nowThe goal of this clinical trial is to study whether the Mosaic Injectable Dermal Implant is a safe and effective treatment for age-related midface volume deficit in adults who are at least 22 years of age. The main questions it aims to answer are: 1. What medical problems do par…
Sponsor: Helios Aesthetics Inc. • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Which training method best prepares midwifery students for injections?
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to compare three simulation-based approaches for teaching subcutaneous injections to first-year midwifery students. A subcutaneous injection is an injection given into the tissue just under the skin. The main questions this study aims to answer …
Sponsor: Ankara University • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
A manufacturing tweak to a cancer drug: will it change how the body responds?
Knowledge-focused Not yet recruitingThis is a randomized, double-blind, parallel-controlled study to compare the PK profile of HLX29 and HLX11 and evaluate their safety, tolerability, and immunogenicity after a single intravenous dose in healthy male adult participants.
Phase 1 • Sponsor: Shanghai Henlius Biotech • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Tingling to dreamland: ASMR put to the test for Post-Surgery sleep
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effects of Autonomous Sensory Meridian Response (ASMR) and white noise on postoperative sleep quality in patients undergoing elective lower extremity surgery. Postoperative sleep disturbances are common after orthopedic surger…
Sponsor: muzeyyen ataseven • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Will a new capsule formula deliver HBW-3220 better?
Knowledge-focused Not yet recruitingThis Phase 1 study will evaluate a new formulation of HBW-3220 capsules in healthy adults. It will compare how much and how quickly HBW-3220 enters the bloodstream after a single 120 mg dose of the new formulation versus the previous formulation under fasting conditions, and afte…
Phase 1 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Could type 1 diabetes hide liver problems in children?
Knowledge-focused Not yet recruitingThis cross-sectional study aims to determine the frequency, pattern, and predictors of liver function test abnormalities among children and adolescents with type 1 diabetes mellitus attending Assiut University Children Hospital.
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
One hard workout may shift proteins tied to aging and brain health
Knowledge-focused Not yet recruitingThe purpose of this study is to investigate the effects of an acute aerobic exercise on irisin, klotho, sirtuin-1, and BDNF levels in the healthy adults. The findings will help understand the physiological impacts of exercise on these biomarkers.
Sponsor: Cemre Didem Eyipinar • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can a copycat drug match the real thing? a trial puts ixekizumab to the test
Knowledge-focused Not yet recruitingThis is a randomised, double-blind, two-arm, parallel group, single-dose study to compare the pharmacokinetics, safety, tolerability, and immunogenicity of ixekizumab (SB35 and Taltz) in healthy participants.
Phase 1 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Immune cell tracking could sharpen lyme disease diagnosis
Knowledge-focused Not yet recruitingLyme borreliosis diagnosis currently relies on clinical assessment and detection of Borrelia-specific antibodies. However, serology does not allow reliable assessment of active infection. Evaluation of the cellular immune response through Borrelia-specific T lymphocyte monitoring…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC